MDGL240816C195000
- 97.50
- +5.34+5.79%
Madrigal Pharmaceuticals Newsroom
Evercore Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $405
Evercore analyst Liisa Bayko maintains $Madrigal Pharmaceuticals(MDGL.US)$ with a buy rating, and maintains the target price at $405.According to TipRanks data, the analyst has a success rate of 45.8%
Express News | JMP Securities Maintains Market Outperform on Madrigal Pharmaceuticals, Raises Price Target to $385
JMP Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Raises Target Price to $385
JMP Securities analyst Jonathan Wolleben maintains $Madrigal Pharmaceuticals(MDGL.US)$ with a buy rating, and adjusts the target price from $381 to $385.According to TipRanks data, the analyst has a
Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Benitec Biopharma (BNTC)
Is Madrigal Pharmaceuticals a Millionaire Maker?
Madrigal Pharmaceuticals Initiated at Neutral by Cantor Fitzgerald
Madrigal Pharmaceuticals Initiated at Neutral by Cantor Fitzgerald
Cantor Fitzgerald Initiates Madrigal Pharmaceuticals(MDGL.US) With Hold Rating
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on $Madrigal Pharmaceuticals(MDGL.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 29.3% and a total a
Is Madrigal Pharmaceuticals Stock a Buy?
Madrigal Pharmaceuticals(MDGL.US) Officer Sells US$532K in Common Stock
$Madrigal Pharmaceuticals(MDGL.US)$ Officer Waltermire Robert E. sold 1,900 shares of common stock on Jun 14, 2024 at an average price of $280 for a total value of $532K.Source: Announcement What is s
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Where Will Madrigal Pharmaceuticals Be in 3 Years?
Madrigal Pharmaceuticals(MDGL.US) Officer Sells US$570K in Common Stock
$Madrigal Pharmaceuticals(MDGL.US)$ Officer Waltermire Robert E. sold 2,000 shares of common stock on Jun 12, 2024 at an average price of $285 for a total value of $570K.Source: Announcement What is s
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Officer Proposes to Sell 532K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Madrigal Pharmaceuticals(MDGL.US)$ Officer ROBERT E. WALTERMIRE intends to sell 1,900 shares of its common stock on Jun 14, with a total market value of approximately
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Officer Proposes to Sell 4.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Madrigal Pharmaceuticals(MDGL.US)$ Officer BRIAN J. LYNCH intends to sell 17,311 shares of its common stock on Jun 14, with a total market value of approximately $4.74
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Officer Proposes to Sell 10.14 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 13, $Madrigal Pharmaceuticals(MDGL.US)$ Officer BRIAN J. LYNCH intends to sell 35,560 shares of its common stock on Jun 13, with a total market value of approximately $10.1
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Officer Proposes to Sell 1.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Madrigal Pharmaceuticals(MDGL.US)$ Officer ROBERT E. WALTERMIRE intends to sell 6,000 shares of its common stock on Jun 12, with a total market value of approximately
Form 144 | Madrigal Pharmaceuticals(MDGL.US) Officer Proposes to Sell 2.79 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Madrigal Pharmaceuticals(MDGL.US)$ Officer BRIAN J. LYNCH intends to sell 9,702 shares of its common stock on Jun 11, with a total market value of approximately $2.79
Madrigal Pharmaceuticals Rallies 15% on Wolfe Research 'Outperform' Rating
Madrigal Pharmaceuticals rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating.
Express News | Madrigal Pharmaceuticals Shares Are Trading Higher After Wolfe Research Initiated Coverage on the Stock With an Outperform Rating
Express News | Wolfe Research Initiates Coverage On Madrigal Pharmaceuticals With Outperform Rating